Novanta's Q2 sales, profit beats estimates
Overview
Novanta Q2 GAAP revenue up 2% to $241 mln, beating estimates
Adjusted EPS for Q2 at $0.76, surpassing analyst expectations
Company updates full-year 2025 financial guidance
Outlook
Novanta expects full-year 2025 GAAP revenue of $970 mln to $985 mln
Company anticipates Q3 2025 GAAP revenue of $244 mln to $247 mln
Novanta sees full-year 2025 Adjusted EBITDA of $225 mln to $230 mln
Company expects Q3 2025 Adjusted EPS of $0.78 to $0.85; FY adjusted EPS of $3.22 to $3.36
Result Drivers
ACQUISITIONS AND FX - Revenue growth driven by acquisitions and favorable foreign exchange rates
BOOKINGS GROWTH - 10% increase in bookings with improvement in industrial business
SEGMENT GROWTH - Mid-teens revenue growth in Advanced Surgery and Robotics & Automation segments
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $241 mln | $238 mln (3 Analysts) |
Q2 Adjusted EPS | Beat | $0.76 | $0.73 (3 Analysts) |
Q2 Consolidated Net Income |
| $4.50 mln |
|
Q2 Adjusted EBITDA | Beat | $52.20 mln | $51.50 mln (2 Analysts) |
Q2 Adjusted Operating Income | Beat | $40.70 mln | $39.90 mln (3 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the electronic equipment & parts peer group is "buy"
Wall Street's median 12-month price target for Novanta Inc is $158.50, about 21.8% above its August 4 closing price of $124.01
The stock recently traded at 33 times the next 12-month earnings vs. a P/E of 32 three months ago
Press Release: ID:nBwrCR1sa
